Um, we don't even know how it's really absorbed in the body
Location: Indianapolis, IndianaWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Zepbound (tirzepatide) and Mounjaro (tirzepatide)FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Eli Lilly promoted Mounjaro and Zepbound in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner, despite FDAs prior correspondence (advisory comments dated June 13, 2022 and June 21, 2022)
The Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act would strengthen oversight of high-volume compounding by requiring transparency in production, mandating FDA inspections before products are distributed, and closing loopholes that allow large-scale operations to function without appropriate accountability
A.ProtchenkoO.et al (2019)
You name it, I had it
Cognitive behavior therapy (CBT), which includes strategies such as stimulus control (for example, going device-free for an hour before bed), relaxation training, and reframing beliefs about sleep, has been shown to be effective in relieving insomnia
